Th1 and Th17 Cells and Associated Cytokines Discriminate among Clinically Isolated Syndrome and Multiple Sclerosis Phenotypes
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Th1 and Th17 Cells and Associated Cytokines Discriminate among Clinically Isolated Syndrome and Multiple Sclerosis Phenotypes
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-06-30
DOI
10.3389/fimmu.2017.00753
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High Interferon-γ Uniquely in Vδ1 T Cells Correlates with Markers of Inflammation and Axonal Damage in Early Multiple Sclerosis
- (2017) Avadhesh Kumar Singh et al. Frontiers in Immunology
- Precision medicine in multiple sclerosis
- (2016) Manuel Comabella et al. CURRENT OPINION IN NEUROLOGY
- Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis
- (2015) Sunny Malhotra et al. Journal of Neuroinflammation
- Immunological differences between classical phenothypes of multiple sclerosis
- (2015) Piotr Iwanowski et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Plasma Biomarkers Discriminate Clinical Forms of Multiple Sclerosis
- (2015) Marta Tejera-Alhambra et al. PLoS One
- Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation
- (2015) Athanasia Mouzaki et al. PLoS One
- Stage-Specific Immune Dysregulation in Multiple Sclerosis
- (2014) Benjamin M. Segal JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS
- (2014) A. K. Huber et al. NEUROLOGY
- Longitudinal T cell-derived IFN-γ/IL-17 balances do not correlate with the disease course in two mouse models of experimental autoimmune encephalomyelitis
- (2013) Stefanie Kuerten et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Distinct Serum Cytokine Profiles in Neuromyelitis Optica and Multiple Sclerosis
- (2013) Kai Chen Wang et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Pathology and disease mechanisms in different stages of multiple sclerosis
- (2013) Hans Lassmann JOURNAL OF THE NEUROLOGICAL SCIENCES
- Body fluid biomarkers in multiple sclerosis
- (2013) Manuel Comabella et al. LANCET NEUROLOGY
- Cytokine profile in relapsing-remitting multiple sclerosis patients and the association between progression and activity of the disease
- (2013) ANA PAULA KALLAUR et al. Molecular Medicine Reports
- Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
- (2013) Jeppe Romme Christensen et al. PLoS One
- A novel data mining system points out hidden relationships between immunological markers in multiple sclerosis
- (2013) Maira Gironi et al. Immunity & Ageing
- Interleukin 17F Level and Interferon Beta Response in Patients With Multiple Sclerosis
- (2013) Hans-Peter Hartung et al. JAMA Neurology
- Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?
- (2012) Jack Antel et al. ACTA NEUROPATHOLOGICA
- Multiple Sclerosis: The Role of Cytokines in Pathogenesis and in Therapies
- (2012) Amedeo Amedei et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Evaluation of Th17-related cytokines and receptors in multiple sclerosis patients under interferon beta-1 therapy
- (2012) Gunes Esendagli et al. JOURNAL OF NEUROIMMUNOLOGY
- Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
- (2012) Jeppe Romme Christensen et al. Journal of Neuroinflammation
- Analysis of Proinflammatory and Anti-Inflammatory Cytokine Serum Concentrations in Patients With Multiple Sclerosis by Using a Multiplexed Immunoassay
- (2011) Thomas B. Martins et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Th17 Cells Are Long Lived and Retain a Stem Cell-like Molecular Signature
- (2011) Pawel Muranski et al. IMMUNITY
- Disease-associated inflammatory biomarker profiles in blood in different subtypes of multiple sclerosis: Prospective clinical and MRI follow-up study
- (2011) Sanna Hagman et al. JOURNAL OF NEUROIMMUNOLOGY
- Progressive Multiple Sclerosis: Characteristics and Management
- (2011) Kathleen Hawker NEUROLOGIC CLINICS
- Human TH17 Cells Are Long-Lived Effector Memory Cells
- (2011) I. Kryczek et al. Science Translational Medicine
- Interferon-β exacerbates Th17-mediated inflammatory disease
- (2011) Robert C. Axtell et al. TRENDS IN IMMUNOLOGY
- Th17/Th1 phenotype in demyelinating disease
- (2010) L.J. Edwards et al. CYTOKINE
- Imbalance in T-cell and cytokine profiles in patients with relapsing-remitting multiple sclerosis
- (2010) Z. Mikulkova et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
- (2010) Robert C Axtell et al. NATURE MEDICINE
- Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis
- (2009) Verena Brucklacher-Waldert et al. BRAIN
- The relation between inflammation and neurodegeneration in multiple sclerosis brains
- (2009) Josa M. Frischer et al. BRAIN
- Unlike Th1, Th17 Cells Mediate Sustained Autoimmune Inflammation and Are Highly Resistant to Restimulation-Induced Cell Death
- (2009) G. Shi et al. JOURNAL OF IMMUNOLOGY
- IL17 and IFNγ production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis
- (2008) Giovanni Frisullo et al. CYTOKINE
- T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis
- (2008) Chris J. Hedegaard et al. IMMUNOLOGY
- A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis
- (2008) Howard L. Weiner JOURNAL OF NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started